119
Participants
Start Date
September 30, 2008
Primary Completion Date
January 31, 2013
Study Completion Date
January 31, 2013
mesalamine
Increase dose by 2.4gm per day over baseline dose
University of Pennsylvania - Presbyterian Medical Center, Philadelphia
Chevy Chase Clinical Research, Chevy Chase
University of Maryland Medical Center, Baltimore
Atlanta Gastroenterology Associates, Atlanta
Shafran Gastroenterology Center, Winter Park
Gastroenterology Group of Naples, Naples
Minnesota Gastroenterology, P.A., Plymouth
South Jersey Gastroenterology, Marlton
Collaborators (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Shire
INDUSTRY
James Lewis
OTHER